WATSON 347 12.5 mg (Hydrochlorothiazide 12.5 mg)
Pill imprint WATSON 347 12.5 mg has been identified as Hydrochlorothiazide 12.5 mg.
Hydrochlorothiazide is used in the treatment of high blood pressure; edema; diabetes insipidus; nephrocalcinosis; osteoporosis and belongs to the drug class thiazide diuretics. There is no proven risk in humans during pregnancy. Hydrochlorothiazide 12.5 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for WATSON 347 12.5 mg
- 12.5 mg
- Turquoise & White
- 14.00 mm
- Prescription only
- Drug Class:
- Thiazide diuretics
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Watson Pharmaceuticals
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide
D&C Red No. 28
D&C Yellow No. 10
FD&C Blue No. 1
FD&C Blue No. 2
FD&C Red No. 40
|NDC Code||Manufacturer / Repackager|
|54569-5236||A S Medication Solutions LLC (repackager)|
|67544-1009||Prepak Systems Inc (repackager)|
|23490-7038||Palmetto State Pharmaceuticals Inc (repackager)|
|57866-6733||Direct Dispensing Inc (repackager)|
|16590-0580||Stat RX USA LLC (repackager)|
|49999-0388||Lake Erie Medical and Surgical Supply (repackager)|
Note: Inactive ingredients may vary.
More about hydrochlorothiazide
- Hydrochlorothiazide capsules
- Hydrochlorothiazide solution
- Hydrochlorothiazide (Advanced Reading)
Related treatment guides
Copyright 2015 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.